I don't think people are realising the impact that this individual will have. Ian was brought in for a reason: To realise the potential of Tuzistra. Vernalis will now have the capability to do this launch properly and I cannot wait until this drug is officially launched.
30 Jun '15
More Skill Onboard
Vernalis plc announces that Dr Ian David Gilham, aged 55, has been appointed to the Board as a Non-Executive Director with effect from 1 July 2015. Dr Gilham will also serve as Chairman of the Company's Remuneration Committee.......... Dr Gilham has international experience in the research, development and commercialisation of diagnostic and pharmaceutical products. He is Non-Executive Chairman of a number of UK and European companies including Epistem Holdings Limited, Concepta Diagnostics Limited, Horizon Discovery Group plc, Multiplicom NV, and Biosurfit SA. Dr Gilham was formerly CEO of Axis-Sheild plc, a FTSE listed global diagnostics company. He also previously worked at GlaxoSmithKline as Vice President - Pharmacogenetics and before that held international general management, marketing business development and R&D positions with Abbott Laboratories, Celltech and Amersham.
15 Jun '15
to a4007035 re Woodford purchase
The share purchase by Woodford was listed in the Regularory News section last Friday. Be happy
15 Jun '15
how do you know this? I topped up about 2 weeks ago around SP 65
14 Jun '15
WOODFORD TOPPED UP ON FRIDAY
Interesting to see that Woodford increased their stake in the company on Friday. I wonder if Invesco will follow in,they often do.
8 Jun '15
this share is now starting to move been here over 6 years now bought in @ 92p so still a litle bit to go yet to break even but getting there slowly but surley cheers.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.